Personalization of cancer treatments with a CLIA-certified high-complexity and high-throughput drug sensitivity test

被引：0
|
作者：
Swan, Hallie A. [1 ]
Churchill, Michael J. [1 ]
Rosati, Rachele [2 ]
Schaub, Franz X. [1 ]
Shaw, Reid C. [2 ]
Watt, Roland M. [1 ]
Mendez, Eduardo [3 ]
Kemp, Christopher J. [4 ]
Gadi, Vijayakrishna K. [4 ]
Murphy, Stephanie A. [1 ]
Bernard, Brady [5 ]
Diaz, Robert L. [1 ]
Pereira, Shalini C. [1 ]
Grandori, Carla [1 ]
机构：
[1] SEngine Precis Med, Seattle, WA USA
[2] Cure First, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[5] Inst Syst Biol, Portland, OR USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1605
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Personalized medicine: A CLIA-certified high-throughput drug screening platform for ovarian cancer
    Swan, Hallie A.
    Rosati, Rachele
    Bridgwater, Caroline
    Churchill, Michael J.
    Watt, Roland M.
    Shaw, Reid C.
    Murphy, Stephanie A.
    Diaz, Robert L.
    Pereira, Shalini C.
    Schaub, Franz X.
    Grandori, Carla
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Clinical and Anatomic Pathology Test Volume by Specialty and Subspecialty Among High-Complexity CLIA-Certified Laboratories in 2011
    Wians, Frank H., Jr.
    Pill, Gary W.
    LABMEDICINE, 2013, 44 (02): : 163 - 167
  • [3] A CLIA-CERTIFIED HIGH-THROUGHPUT DRUG SCREENING PLATFORM FOR OVARIAN CANCER TO INFORM PERSONALIZED CANCER CARE AND DISCOVER NOVEL COMBINATIONS
    Schaub, Franz X.
    Maisel, Sabrina
    Shaw, Reid
    Rosati, Rachele
    Bridgwater, Caroline
    Churchill, Michael
    Diaz, Robert
    Murphy, Stephanie Tatem
    Pereira, Shalini
    Kemp, Christopher
    Gadi, V. K.
    Grandori, Carla
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 114 - 114
  • [4] A CLIA-certified functional precision medicine assay, the PARIS© test, to predict drug response for ovarian cancer
    Richardson, A.
    Dullea, A.
    Stecher, H.
    Pereira, S.
    Musa, F.
    Schaub, F. X.
    Margossian, A. L.
    Grandori, C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 147 - 148
  • [5] High-throughput Drug Repositioning for the Discovery of New Treatments for Chagas Disease
    Bellera, Carolina L.
    Sbaraglini, Maria L.
    Balcazar, Dario E.
    Fraccaroli, Laura
    Cristina Vanrell, M.
    Florencia Casassa, A.
    Labriola, Carlos A.
    Romano, Patricia S.
    Carrillo, Carolina
    Talevi, Alan
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2015, 15 (03) : 182 - 193
  • [6] Developing a high-throughput, high content screening technology to identify new anticancer drug treatments
    Milcarek, Andrew T.
    Daus, Kevin
    Alpaugh, Mary L.
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Engineering a Brain Cancer Chip for High-throughput Drug Screening
    Fan, Yantao
    Duong Thanh Nguyen
    Akay, Yasemin
    Xu, Feng
    Akay, Metin
    SCIENTIFIC REPORTS, 2016, 6
  • [8] Engineering a Brain Cancer Chip for High-throughput Drug Screening
    Yantao Fan
    Duong Thanh Nguyen
    Yasemin Akay
    Feng Xu
    Metin Akay
    Scientific Reports, 6
  • [9] High-throughput screening of cancer spheroids demonstrates sensitivity to combination chemotherapy
    Katz, Elad
    Deehan, Maureen R.
    Petty, Russell D.
    Davies, Paul
    CANCER RESEARCH, 2022, 82 (12)
  • [10] An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
    Jonas, Oliver
    Landry, Heather M.
    Fuller, Jason E.
    Santini, John T., Jr.
    Baselga, Jose
    Tepper, Robert I.
    Cima, Michael J.
    Langer, Robert
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (284) : 284ps10
12345